Skip to main content

Table 2 Medical factors associated with delays in tuberculosis treatment

From: Delay in the treatment of pulmonary tuberculosis: a report from Afghanistan

Variable

N (%)

Patient delay

Health-system delay

Days, mean (SD)

Days, mean (SD)

Sputum production

 No

3 (2.5)

83 (138.6)

264.3 (285.3)

 Yes

119 (97.5)

208.3 (126.3)

147.9 (104.5)

Fever

 No

14 (11.5)

71.9 (62.9)***

178.2 (149.7)

 Yes

108 (88.5)

222.5 (123.6)***

147.2 (105.4)

Hemoptysis

 No

66 (54.6)

184.9 (139.3)*

154.4 (133.6)

 Yes

55 (45.4)

230.8 (108.6)*

144.2 (76.3)

Chest pain

 No

21 (17.2)

86.0 (107.5)***

177.6 (172.0)

 Yes

101 (82.8)

230.0 (117.2)***

145.2 (93.9)

Weight loss

 No

37 (30.3)

173.0 (155.5)

162.4 (140.4)

 Yes

85 (69.7)

219.2 (111.3)

145.6 (96.0)

Coexistence of chronic conditionsa

 No

113 (92.6)

198.3 (128.1)*

150.1 (114.4)

 Yes

9 (7.4)

291.1 (84.7)*

158.2 (55.8)

  1. Significance of difference by two-sample t-tests; *p < 0.05; ***p < 0.001
  2. aChronic conditions include acquired immunodeficiency syndrome (AIDS), diabetes, chronic obstructive pulmonary disease (COPD), disability, and others